Hyperhidrosis – excessive sweating – is an issue that troubles many individuals, impacting daily life, self-confidence, and social interactions. Especially before the beginning of the summer months, the problem becomes even more intense with the rise in temperature. Fortunately, modern aesthetic medicine offers a highly effective solution: the application of Btx.
Btx is widely known for its use in reducing wrinkles. However, it has also been recognized by the medical community for its effectiveness in significantly reducing excessive sweating, particularly in the armpits, palms, and soles. Its approval by the U.S. Food and Drug Administration (FDA) for the treatment of primary hyperhidrosis confirms both its safety and efficacy.
The procedure is simple and quick: the doctor performs a painless diagnostic test to accurately determine which areas of the sweat glands are overactive. These areas are then marked, and Btx is administered through small injections. The medication temporarily blocks the nerves that activate the sweat glands, significantly reducing sweat production. Results are visible within a few days and last on average 6 to 9 months.
This is a non-invasive and nearly painless treatment, with no recovery time required. Many patients choose it before summer so they can feel comfortable in their clothing, free from sweat stains and the embarrassment these may cause.
If hyperhidrosis is affecting your quality of life, a visit to your doctor can relieve you from this daily discomfort. Btx is not only for aesthetics – it is also a solution for a better quality of life.
Book your appointment today and welcome the summer with confidence and comfort!
References
- Patel T et al. (2024). Assessing Botulinum Toxin Effectiveness and Quality of Life in Axillary Hyperhidrosis: A One-Year Prospective Study. https://doi.org/10.3390/diseases12010015
- Nowak M et al. (2024). Treatment of Primary Axillary Hyperhidrosis with Two Doses of Botulinum Toxin A—Observational Study. https://doi.org/10.3390/toxins16070320
- Zhao Y et al. (2025). Efficacy and Safety of Botulinum Toxin Type A in Primary Axillary Hyperhidrosis: A Meta-Analysis. https://pubmed.ncbi.nlm.nih.gov/40500510
